# Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza

> **NCT01227798** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 30 (estimated)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Interferon alfacon-1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01227798
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01227798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01227798, "Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01227798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*